Potential coronavirus vaccine from Novavax shows positive early symptoms


Rafael Mendoza, President of AstraZeneca for the Central America and Caribbean region, said: "At AstraZeneca, we reaffirm our commitment to promote broad and equitable access to the AZD1222 candidate vaccine in Central America and the Caribbean if it is safe and effective". Another volunteer, identified as Carrie, said she received her first shot of the Pfizer coronavirus vaccine way back in September and another in October.

Kroger, Meijer, Walgreens and CVS locations will all be able to distribute the COVID-19 vaccine for free - as soon as it exists.

Two vaccines that are finishing up their phase three trials are expected to file with the FDA for emergency use authorization within the next few weeks, Dr. Moncef Slaoui, who is managing Operation Warp Speed's coronavirus vaccine development efforts, said during a press conference Friday at the White House.

Pharma major Dr Reddy's Laboratories Ltd will be completing phase two trials of Covid vaccine candidate Sputnik V in December.

Brazil halts Chinese-made COVID-19 vaccine trials
Worldwide, there are at least 10 vaccine candidates in late-stage clinical trials, according to the World Health Organization. Since July, Sinovac has launched large-scale trials in several countries including Brazil, Indonesia, and Turkey.

Experts stated that the Russian data was promising and strengthened the idea that the coronavirus pandemic could be stemmed by vaccines, while cautioning that the results were only predicated on a small number of study participants who had contracted COVID-19.

Russia's sovereign wealth fund, has tied up with Dr Reddy's to conduct the clinical trials and distribution of Sputnik V vaccine in India.

The Pfizer COVID-19 vaccine needs to be kept at -70 degrees Celsius and such logistics could be hard to arrange in India, especially in rural areas, said AIIMS Director Dr Randeep Guleria.

Interim trial data from Pfizer and BioNTech released on Monday indicated that its vaccine candidate was more than 90% effective.